echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > AJG: Autoimmune hepatitis patients at significantly increased cancer risk

    AJG: Autoimmune hepatitis patients at significantly increased cancer risk

    • Last Update: 2022-02-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that usually requires long-term immunosuppressive therapy (IST)


    Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease that usually requires long-term immunosuppressive therapy (IST)


     

    The researchers identified all people diagnosed with AIH between 1994 and 2018 by collecting a Danish population database


    diagnosis

     

    The results found that the RR for the 10-year risk of developing any cancer was 1.


    colorectal cancer

    Figure: The relationship between the prevalence of AIH and the incidence of cancer

    The present study demonstrated a 1.


    The present study demonstrated a 1.


    Jensen, Morten D.


    Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study.


    Leave a Comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.